Global Cough Remedies Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cough Remedies Sales Market Report 2024
Market Analysis and InsightsGlobal Cough Remedies Market
Cough is a reflex action that clears the throat from fluids, irritants, foreign particles, and microbes. It is majorly caused by virus or bacteria, smoking, asthma, and other factors. Cough drops and suppressants are majorly given to the patient to cure cough. Sometimes, the patient is also advised to drink plenty of water, as a measure for cough remedy.
Due to the COVID-19 pandemic, the global Cough Remedies market size is estimated to be worth US$ 9120.9 million in 2024 and is forecast to a readjusted size of US$ 13410 million by 2034 with a CAGR of 5.6% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Antihistamines accounting for % of the Cough Remedies global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The United States Cough Remedies market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Cough Remedies include Johnson & Johnson, Bayer, GlaxoSmithKline, AstraZeneca, Pfizer, Sun Pharmaceutical and Novartis, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Cough Remedies Scope and Market Size
The global Cough Remedies market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Cough Remedies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Johnson & Johnson
Bayer
GlaxoSmithKline
AstraZeneca
Pfizer
Sun Pharmaceutical
Novartis
Cough is a reflex action that clears the throat from fluids, irritants, foreign particles, and microbes. It is majorly caused by virus or bacteria, smoking, asthma, and other factors. Cough drops and suppressants are majorly given to the patient to cure cough. Sometimes, the patient is also advised to drink plenty of water, as a measure for cough remedy.
Due to the COVID-19 pandemic, the global Cough Remedies market size is estimated to be worth US$ 9120.9 million in 2024 and is forecast to a readjusted size of US$ 13410 million by 2034 with a CAGR of 5.6% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Antihistamines accounting for % of the Cough Remedies global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The United States Cough Remedies market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Cough Remedies include Johnson & Johnson, Bayer, GlaxoSmithKline, AstraZeneca, Pfizer, Sun Pharmaceutical and Novartis, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Cough Remedies Scope and Market Size
The global Cough Remedies market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Cough Remedies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Johnson & Johnson
Bayer
GlaxoSmithKline
AstraZeneca
Pfizer
Sun Pharmaceutical
Novartis
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices